Genetic consequences of mass human chemotherapy for Schistosoma mansoni: population structure pre- and post-praziquantel treatment in Tanzania.
about
A research agenda for helminth diseases of humans: towards control and eliminationImmunoprotection of mice against Schistosomiasis mansoni using solubilized membrane antigensIn vitro and in vivo anti-schistosomal activity of the alkylphospholipid analog edelfosineStructural basis for the inhibition of histone deacetylase 8 (HDAC8), a key epigenetic player in the blood fluke Schistosoma mansoniA research agenda for helminth diseases of humans: basic research and enabling technologies to support control and elimination of helminthiasesNew insights into the molecular epidemiology and population genetics of Schistosoma mansoni in Ugandan pre-school children and mothersPraziquantel treatment decreases Schistosoma mansoni genetic diversity in experimental infectionsNo apparent reduction in schistosome burden or genetic diversity following four years of school-based mass drug administration in mwea, central kenya, a heavy transmission areaReconstructing Colonization Dynamics of the Human Parasite Schistosoma mansoni following Anthropogenic Environmental Changes in Northwest SenegalLow genetic diversity in wide-spread Eurasian liver fluke Opisthorchis felineus suggests special demographic history of this trematode speciesGenetic diversity within Schistosoma haematobium: DNA barcoding reveals two distinct groupsThe contribution of mass drug administration to global health: past, present and future.Epigenetic control of gene function in schistosomes: a source of therapeutic targets?A research agenda for helminth diseases of humans: modelling for control and elimination.In vitro praziquantel test capable of detecting reduced in vivo efficacy in Schistosoma mansoni human infections.Leishmania donovani populations in Eastern Sudan: temporal structuring and a link between human and canine transmissionPraziquantel sensitivity of Kenyan Schistosoma mansoni isolates and the generation of a laboratory strain with reduced susceptibility to the drug.This de-wormed world?Schistosoma mansoni population structure and persistence after praziquantel treatment in two villages of Bahia, Brazil.Therapeutic efficacy and macrofilaricidal activity of doxycycline for the treatment of river blindnessHigh genetic variability of Schistosoma haematobium in Mali and NigeriaNew insights into the genetic diversity of Schistosoma mansoni and S. haematobiumin YemenCan human schistosomiasis mansoni control be sustained in high-risk transmission foci in Egypt?Genetic Diversity of Schistosoma haematobium Eggs Isolated from Human Urine in Sudan.Whole genome resequencing of the human parasite Schistosoma mansoni reveals population history and effects of selectionReduced Efficacy of Praziquantel Against Schistosoma mansoni Is Associated With Multiple Rounds of Mass Drug AdministrationEstimation of changes in the force of infection for intestinal and urogenital schistosomiasis in countries with schistosomiasis control initiative-assisted programmes.Whole Genome Amplification and Reduced-Representation Genome Sequencing of Schistosoma japonicum Miracidia.Repeated praziquantel treatments remodel the genetic and spatial landscape of schistosomiasis risk and transmission.The Efficacy of Single-Dose versus Double-Dose Praziquantel Treatments on Schistosoma mansoni Infections: Its Implication on Undernutrition and Anaemia among Primary Schoolchildren in Two On-Shore Communities, Northwestern Tanzania.Population genetics of Schistosoma haematobium: development of novel microsatellite markers and their application to schistosomiasis control in Mali.Detection of duo-schistosome infection from filtered urine samples from school children in Zambia after MDA.Phenotypic and genotypic monitoring of Schistosoma mansoni in Tanzanian schoolchildren five years into a preventative chemotherapy national control programme.Developing novel strategies to prevent parasitic infections.
P2860
Q21562257-38E00E2C-C29D-4E0F-8601-24CA1DCFA2B9Q27305172-AF080D9C-88C8-487E-9D3E-AAC7F196CBB3Q27339703-30A8F557-CE0F-4DBE-94D9-7AE8603218E8Q27680126-11024169-425A-454B-9033-E5F96555D80EQ28482492-CF9D4E48-DB87-49B7-98C4-BB514AC621A5Q28537580-BF6CB3B8-F07E-4B8B-891F-5A3A315DEE56Q28537753-93A4194B-04FB-48B6-9694-A58645F972D2Q28543650-E7EEDE03-4866-4450-BB53-7E6F81995C56Q28547289-97E6A4B3-BA1B-440F-AD5E-2205C72CB585Q28708619-F5812C33-BF2B-4C4B-B079-954FAF6A686AQ28714178-7F4665CA-23BF-4D1E-910C-FC4D256A7396Q30388508-D82404B1-7FA7-421B-80CE-5F6016403E4EQ34159188-786BABA8-B210-48ED-BED0-2B40F202FC37Q34251353-AD17B61A-4A30-4876-BB1C-530253EBBA19Q34341901-60D24A14-37E2-44C1-8D32-EE811E85CCFDQ34630140-55778133-0E6F-478C-BF3C-C3B2C0BA4691Q34705447-CF823F65-B581-429B-BE5F-9E8AA859E4CEQ34986489-97056D25-6E94-4174-9553-BA6887561BCAQ35163069-08DF5044-45FC-4999-8C5C-67C042029D2BQ35207455-25B05B23-17E1-4977-956B-AAA276C3E3BAQ35262137-A0E83694-BE04-412D-8259-916E9688FC90Q35813630-80C17AA7-A3E0-4981-AFE4-7ADCC43AE47FQ35852720-CE6C1379-5387-4C98-B0CD-BE9D324CC408Q35877658-AA629718-E2FA-4ECD-A6BC-B5A404943C1CQ35924330-EE7C1519-0681-4ACD-BD95-EB3BD757D63DQ36089146-A21EEB90-6051-4119-8660-A52536999736Q36204615-DCE42360-6760-4AD7-818B-E984DE056DD3Q36255302-43A912C5-7C38-4839-91A9-3583A3A0E557Q36835132-83D942D3-EF8A-4018-B410-376F66D74A2FQ43924119-611ED190-8153-4B92-A176-4BC514D5D402Q46188046-F7D4BFBB-0FF5-4D8D-882A-C34AD5B5C61CQ46243865-BBA9C967-D980-4CE8-A230-1D66C1CAC446Q46249533-010B0E10-A18F-47D2-B190-20C28E908D79Q47987209-0BF0270E-39A7-4952-AD6E-45F391220A4A
P2860
Genetic consequences of mass human chemotherapy for Schistosoma mansoni: population structure pre- and post-praziquantel treatment in Tanzania.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Genetic consequences of mass h ...... quantel treatment in Tanzania.
@ast
Genetic consequences of mass h ...... quantel treatment in Tanzania.
@en
Genetic consequences of mass h ...... quantel treatment in Tanzania.
@nl
type
label
Genetic consequences of mass h ...... quantel treatment in Tanzania.
@ast
Genetic consequences of mass h ...... quantel treatment in Tanzania.
@en
Genetic consequences of mass h ...... quantel treatment in Tanzania.
@nl
prefLabel
Genetic consequences of mass h ...... quantel treatment in Tanzania.
@ast
Genetic consequences of mass h ...... quantel treatment in Tanzania.
@en
Genetic consequences of mass h ...... quantel treatment in Tanzania.
@nl
P2093
P2860
P921
P1476
Genetic consequences of mass h ...... quantel treatment in Tanzania.
@en
P2093
Alice J Norton
Charlotte M Gower
Joanne P Webster
Lynsey Blair
Nicholas J S Lwambo
Poppy H L Lamberton
P2860
P304
P356
10.4269/AJTMH.2010.10-0283
P407
P577
2010-10-01T00:00:00Z